Digital learning initiative advances biomarker-guided therapy in pediatric asthma :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

E-learning initiative supports early intervention to preserve lung function in pediatric asthma

Pediatric asthma Pediatric asthma
Pediatric asthma Pediatric asthma

What's new?

A 15-minute on-demand e-learning program increases clinician knowledge and competence by 103% and drives earlier biologic use in pediatric moderate-to-severe asthma.

A new United States (US)-based educational initiative highlights the fundamental role of guideline-concordant care and early biologic intervention in preserving long-term lung function in children with moderate-to-severe asthma. Despite the availability of advanced add-on biologic therapies, overreliance on oral corticosteroids remains common in clinical practice—raising concerns about suboptimal long-term respiratory outcomes.

To address this gap, a brief, 15-minute on-demand medical training module featuring two leading experts determined the impact of early biologic therapy on long-term lung function in pediatric asthma. The program targeted pulmonologists, allergists/immunologists, and pediatricians across the US. A total of 4,029 clinicians completed the activity. Pre- and post-activity assessments measured alteration in knowledge, clinical competence, confidence, and intended practice behavior.

Key findings

The program delivered measurable improvements across multiple performance domains:

  • There was 103% overall improvement in knowledge and clinical competence.
  • The largest knowledge gain was noted in understanding the long-term impact of childhood asthma on lung function trajectory.
  • Remarkable improvement was also noted in awareness of the efficacy of biologics in improving pediatric lung function.
  • Competence in adjusting biologic therapy based on clinical trial response increased, with allergists/immunologists demonstrating the greatest gains among specialties.
  • The capability to apply evidence-informed strategies for optimizing lung function improved by 75% overall.
  • 71% of subjects reported intent to change clinical practice—particularly in considering earlier initiation of biologics and incorporating biomarker analysis to personalize pediatric asthma care.

Given that participants reported treating approximately 4–7 pediatric asthma patients per week, these intended changes could influence nearly 16,000 patient interactions, underscoring the program’s potential real-world impact.

The findings demonstrate that brief, expert-led, on-demand digital education can improve clinician readiness to integrate biologics into individualized pediatric asthma care. Importantly, the results also reveal persistent educational gaps—particularly in incorporating longitudinal lung function assessment into routine clinical decision-making. Future educational initiatives focusing on precision medicine, biomarker-driven therapy, and early biologic intervention may further minimize corticosteroid overuse and help preserve long-term pulmonary outcomes in children battling asthma.

Source:

Annals of Allergy, Asthma & Immunology

Article:

EARLY INTERVENTION FOR OPTIMIZING LUNG FUNCTION IN PEDIATRIC ASTHMA: IMPACT OF ON-DEMAND MEDICAL EDUCATION E-LEARNING

Authors:

D. Bonder et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: